KEI argues that two sections of the law—35 U.S.C. § 202(c)(4) and 28 U.S.C. 1498—allow the administration to license Xtandi patents to companies …
KEI argues that two sections of the law—35 U.S.C. § 202(c)(4) and 28 U.S.C. 1498—allow the administration to license Xtandi patents to companies …